BRUCE
LEE EVATT, M.D.
Present
Positions:Chief, Hematologic Diseases Branch
Division of AIDS, STD, and TB Laboratory Research
Centers
for Disease Control
1600
Clifton Road, N.E.
Mailstop E64
Atlanta, Georgia 30333
Education:1953 1957Wayne High School
Wayne,
Oklahoma
1957
1960University of Oklahoma
Norman,
Oklahoma
1960
1964University of Oklahoma School of Medicine
Oklahoma City, Oklahoma M.D.
Appointments:1964 1965Intern, Osler Medical Service
The
Johns Hopkins Hospital
1965
1966Assistant Resident, Osler Medical Service
The
Johns Hopkins Hospital
1966
1968Fellow in Hematology, The Johns Hopkins Hospital
1968
1970Epidemic Intelligence Officer, NCDC, United States
Public Health Service, Atlanta, Georgia
1968
1970 Clinical Instructor in Medicine
Emory
University School of Medicine
1970
1971Senior Resident, Osler Medical Service
The
Johns Hopkins Hospital
1971
1972Fellow in Hematology
The
Johns Hopkins Hospital
1972
1973Chief Resident in Medicine
The
Johns Hopkins Hospital
1972
1973Instructor in Medicine
The
Johns Hopkins Hospital
1973
1976Assistant Professor of Medicine
The
Johns Hopkins University School of Medicine
1973
1976Assistant Physician
The
Johns Hopkins Hospital
1973
1976Investigator of Howard Hughes Medical Center
1976
1978Chief, Thrombosis and Hemostasis Branch
Hematology Division
Center
for Disease Control
Atlanta, Georgia
1976
1991Associate Professor
Emory
University School of Medicine
Atlanta, Georgia
1978
1982Director, Hematology Division
Centers
for Disease Control
Atlanta, Georgia
1982
1991Director, Division of Immunologic, Oncologic, and
Hematologic Diseases
Center
for Infectious Diseases
Centers
for Disease Control
Atlanta, Georgia
1991 -
PresentClinical Professor
Emory
University School of Medicine
Atlanta, Georgia
1991 -
PresentAssistant Director for Hemophilia Activities,
Division of HIV/AIDS
National Center for Infectious Diseases
Centers
for Disease Control
Atlanta, Georgia
1991 -
PresentChief, Hematologic Diseases Branch
Division of HIV/AIDS
National Center for Infectious Diseases
Centers
for Disease Control
Atlanta, Georgia
Medical
License:Oklahoma, June 17, 1964
Maryland, August 19, 1966
Georgia, October 14, 1969
Certification:1973, American Board of Internal Medicine
1974,
American Board of Hematology
1972,
Board Eligible, Oncology
Consultant Appointments:
Consultant in Hematology, Fort Howard Veterans
Administration Hospital
World
Health Organization
Editorial Boards
Ad
Hoc Reviewer:American Journal of Medicine
American Journal of Public Health
Annals
of Internal Medicine
BLOOD
The Journal of the American Society of Hematology
Journal
of Acquired Immune Deficiency Syndromes
Journal
of the American Medical Association
Journal
of Laboratory Clinical Medicine
New
England Journal of Medicine
Committees:1976CDC Liaison to International Society for
Thrombosis and Hemostasis
1977National Committee for Clinical Laboratory Standards
Subcommittee on Coagulation
19771984Medical Director and Member, Board of Directors,
Hemophilia of Georgia
19791983American Society of Hematology, Subcommittee on
Clinical Laboratory Standards
19791984CDC Liaison to International Committee for
Standardization in Haematology
19831987American Society of Hematology, Subcommittee on
Hemostasis
19841990Public Health Service AIDS Task Force on Blood
and Blood Products
19851990National Hemophilia Foundation AIDS Task Force
Committee
1987FDA
Blood and Blood Products Advisory Committee
19881991National Blood Resource Education Program
Coordinating Committee, PHS, NIH, NHLBI (National Heart,
Lung, and Blood Institute)
19881995Chairman, AIDS Education Committee World
Federation of Hemophilia
19881994Medical Secretary, World Federation of
Hemophilia
1994-PresentMember Executive Committee, World Federation
Hemophilia
2000-PresentVice-President Developing World. World
Federation of Hemophilia
Societies:1958 Sigma Pi Sigma (Honorary Physics
Society)
1965
AOA (Honorary Medicine)
1972
American Federation for Clinical Research
1977
American Society of Hematology
1986
Sigma Xi
Awards:1973 The Francis S. Schwentker Award for
Research,
Johns Hopkins University
1983
PHS Award, Hemophilia Association of New Jersey
1984
Stewart Wolfe Lectureship, University of Oklahoma
1984
PHS Commendation Medal
1985
Dr. Murray Thelin Award for Distinguished Research
1985
Dr. L. Michael Kuhn Award for Outstanding Governmental
Leadership
1987
PHS Meritorious Service Medal
PUBLICATIONS
1.Smith EW, Evatt BL. Electrophoresis of hemoglobins
following the application of whole blood samples to
acrylamide gel. J Lab Clin Med 69:10181024, 1967.
2.Evatt BL, Mondzac AM, Gaintner JR. Chronic monocytic
leukemia: a clinical appraisal. Ann Int Med (Abst)
66:1041, 1967.
3.Evatt BL, Levin J. Measurement of thrombopoiesis in
rabbits using 75selenomethionine. J Clin Invest
48:16151626, 1969.
4.McIntyre PA, Evatt BL, Hodkinson BA, Scheffel U.
Selenium75 selenomethionine as a label for erythrocytes,
leukocytes, and platelets in man. J Lab Clin Med
75:472480, 1970.
5.Kyle RA, Herber L, Evatt BL, Heath CW. Multiple
myeloma. JAMA 213:13391341, 1970.
6.Levin J, Shreiner DP, Evatt BL. Studies of
thrombopoiesis using selenomethionine75 SE. In:
Platelet Kinetics. Paulus JM, ed. NorthHolland
Publishing Company, pp. 126130, 1971.
7.Levin J, Shreiner DP, Evatt BL. Assay of
thrombopoietin in rabbits using 75 SEselenomethionine.
In: Platelet Kinetics. Paulus JM, ed. NorthHolland
Publishing Company, pp. 152157, 1971.
8.Evatt BL, Dowdle W, Johnson M, Heath CW. Epidemic
mycoplasma pneumonia. New Engl J Med 285:374378, 1971.
9.Heath CW, Evatt BL. Observations concerning the
timespace distributions of childhood acute leukemia in
DeKalb County, Georgia. In: Proceedings of the 6th
Annual Conference on Trace Substances in Environmental
Health. Hemphill DD, ed. University of Missouri, pp.
2327, 1973.
10.Evatt BL, Chase, GA, Heath CW. Timespace clustering
among cases of acute leukemia in two Georgia counties.
Blood 41:265272, 1973.
11.Evatt BL, Shreiner DP, Levin J. Thrombpoietic
activity of fractions of rabbit plasma: studies in
rabbits and mice. J Lab Clin Med 83:364371, 1974.
12.Levin J,
Evatt BL, Shreiner DP. Measurement of plasma
thrombopoiesis stimulating activity using
selenomethionine 75 SE: studies in rabbits and mice.
In: Platelets: Production, Function, Tranfusion, and
Storage. Baldini MG, Ebbe S, eds. Grune and Stratton,
pp. 6372, 1974.
13.Evatt BL, Spivak JL, Levin J. Relationships between
thrombopoiesis and erythropoiesis: with studies of the
effects of preparation of thrombopoietin and
erythropoietin. Blood 48:547558, 1976.
14.Scheffel U, McIntyre PA, Evatt BL, Dvornicky JA,
Natarajan TK, Bolling D, Murphy EA. Evaluation of
indiumIII as a new high photon yield gammaemitting
"physiological" platelet label. John Hopkins Med J
140:285293, 1977.
15.Alving BM, Bell WR, Evatt BL. Fibrinogen synthesis
in rabbits: effects of altered levels of circulating
fibrinogen. Am J Physiol 232(5):H478H484, 1977.
16.Alving BA, Evatt BL, Bell WR. Stimulation of
fibrinogen synthesis by thrombin in rabbits with
ancrodinduced afibrinogemia. Am J Physiol
233(5):H562H567, 1977.
17.Evatt BL. Computerized calculation of platelet
counts obtained with particle counters. Johns Hopkins
Med J 141:163166, 1977.
18.Evatt BL, Alving BA, Bell WR, Levin J. Platelet and
fibrinogen production: relative sensitivities to
endotoxin. Thromb Haemost (Abst) 38:30, 1977.
19.Alving BM, Shulman NR, Bell WR, Evatt BL, Tuck KM.
In vitro studies of heparinassociated thrombocytopenia.
Thromb Res 11:827834, 1977.
20.Evatt BL. Monitoring of anticoagulant therapy the
prothrombin time. Center for Disease Control, p. 52,
1978.
21.Evatt BL. Kinetics of isotopically labeled
platelets. In: CRC Handbook of Hematology. Schmidt RM,
ed. pp. 263272, 1979.
22.Evatt BL. Platelet production. In: CRC Handbook
of Hematology. Schmidt RM, ed. pp. 255261, 1979.
23.Sibley C, Evatt BL. Improving the sensitivity of
the Fletcher factor assay. Am J Clin Path 71:570573,
1979.
24.Alving BM, Evatt BL, Levin J, Bell WR, Ramsey RB,
Levin FC. Platelet and fibrinogen production: relative
sensitivities to endotoxin. J Lab Clin Med 93:437448,
1979.
25.Ramsey R, Evatt BL. Rapid assay for von
Willebrand's factor activity using formalinfixed
platelets and microtitration technique. Am J Clin Path
93:437448, 1979.
26.Stein SF, Evatt BL. Antiplatelet medication and
cardiovascular disease. In: Supplement to the Heart.
Hurst WJ, ed. McGraw Hill, pp. 291303, 1979.
27.Evatt BL, Sibley C. Antithrombin III. DHEW
publication. p. 49, 1979.
28.Levin J, Evatt BL. Humoral control of
thrombopoiesis. Blood Cells 5:105121, 1979.
29.Evatt BL, Levin J, Algazy KM. Partial purification
of thrombopoietin from the plasma of thrombocytopenic
rabbits. Blood 54:377388, 1979.
30.Evatt B. The prothrombin time and the clinical
laboratory. American Society of Clinical Pathologists,
Check Sample, Thrombosis and Hemostasis No. TH6, 1979.
31.Evatt BL. Platelet function and the clinical
laboratory. DHEW publication CDC 7962. p. 11, 1979.
32.Fulenwider JT, Sibley C, Stein SF, Evatt, B,
Nordlinger BM, Ivey GL. The endotoxemia of cirrhosis
an observation not substantiated. Gastroenterology
78:10011004, 1980.
33.Ramsey RB, Hamner MB, Alving BM, Finlayson JS,
Alving CR, Evatt BL. Effects of lipid A and liposomes
containing lipid A on platelet and fibrinogen production
in rabbits. Blood 56:307310, 1980.
34.Barnhart MI, Kim TH, Evatt BL, Ragab AH, Lue VK,
Herman J, Lusher JM. Essential thrombocythemia in a
child: platelet ultrastructure and function. Am J
Hemat 8:87107, 1980.
35.Waitzman MB, Cornelius LM, Evatt BL. Treatment of
canine spontaneous diabetes mellitus with aspirin.
Metabolic Pediatric Opthalmology 4:151154, 1980.
36.Hudson EM, Ramsey RB, Evatt BL. Subcellular
localization of indiumIII in indiumIII labeled
platelets. J Lab Clin Med 97(4):577582, 1981.
37.Evatt BL, van Assendelft O. Coagulation,
standardization, and the 1980's." In: Perspectives in
Hemostasis. Fareed J, Messmore HL, Fenton JW,
Brinkhouse KM, eds. Pergamon Press, pp. 373381, 1981.
38.Stein SF, Fulenwider JT, Ansley JD, Evatt, BL,
Nordlinger B, McLemore P, Schwotzer L, Wideman CS.
Accelerated fibrinogen and platelet destruction after
peritoneovenous shunting. Arch Intern Med 141:11491151,
1981.
39.Fulenwider JT, Stein SF, Wideman CS, Evatt BL.
Reply to letter to editor: Endotoxemia and cirrhosis
and endotoxemia in liver disease. Gastroenterology
80:418419, 1981.
40.Fulenwider JT, Stein SF, Wideman CS, Evatt BL.
Reply to letter to editor: Endotoxemia in cirrhosis.
Gastroenteology 80:1613, 1981.
41.Fulenwider JT, Stein SF, Wideman CS, Evatt BL.
Reply to letter to editor: Endotoxin and cirrhosis.
Gastroenterology 81:636637, 1981.
42.Evatt BL. Oral Anticoagulants. In:
Interpretations in therapeutic drug monitoring. Baer
DM, Dito WR, eds. ASCP, pp. 7488, 1981.
43.Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ,
Wideman C. Deficiency of protein C in congenital
thrombotic disease. J Clin Invest 68:13701373, 1981.
44.Evatt BL, Brogan D, Triplett D, Koepke J, Waters G.
Effect of thromboplastin and instrumentation on the
prothrombin time test. Clin Lab Haematol 3(4):331342,
1981.
45.Evatt BL, Kellar KL. The evolution of techniques
for the study of megakaryocyte growth factors. In:
Megakaryoctye Biology and Precursors: In Vitro Cloning
and Cellular Properties. Evatt BL, Levine RF, Williams
NT, eds. Elsevier/NorthHolland, pp. 1519, 1981.
46.Kellar KL, Evatt BL, McGrath CR, Ramsey RB.
Stimulation of DNA synthesis in megakaryocytes by
thrombopoietin in vitro. In: Megakaryoctye Biology and
Precursors: In Vitro Cloning and Cellular Properties.
Evatt BL, Levine RF, Williams NT, eds.
Elsevier/NorthHolland, pp. 2137, 1981.
47.Evatt BL. Monitoring of oral anticoagulant
therapy. In: Laboratory Evaluation of Coagulation.
Triplett DA, ed. American Society of Clinical
Pathologists Press, pp. 245269, 1982.
48.Evatt BL, Brogan D, Triplett D, Koepke J, Waters G.
Influences of thromboplastin and instrumentation upon
prothrombin time tests: implications for
standardization. In: Standardization of Coagulation
Assays: An Overview. Triplett DA, ed. CAP
Conference/Aspen 1980, pp. 3949, 1982.
49.Gralnick HR, Evatt BL, Huseby RM, Triplett DA.
Procedural standards for the prothrombin time. In:
Standardization of Coagulation Assays: An Overview.
Triplett DA, ed. CAP Conference/Aspen 1980, pp. 5155,
1982.
50.Rose M,
Wideman CS, Evatt BL, Haff E. A comparison of
antithrombin III procedures. Clin Lab Haemat 5:185195,
1983.
51.Evatt BL, Francis DP, McLane MF, Lee TH, Cabradilla
C, Stein SF, Lawrence DN, McDougal JS, Spira TJ, Mullens
JI, Essex M. Antibodies to human T cell leukaemia
virusassociated membrane antigens in haemophiliacs:
evidence for infection before 1980. Lancet ii:698700,
1983.
52.Essex M, McLane MF, Lee TH, Tachibana N, Mullins JI,
Kreiss J, Kasper CK, Poon MC, Landay A, Stein SF,
Francis DP, Cabradilla C, Lawrence DN, Evatt BL.
Antibodies to human T cell leukemia virus membrane
antigens (HTLVMA) in hemophiliacs. Science
221:10611064, 1983.
53.Curran JW, Evatt BL, Lawrence DN. Acquired immune
deficiency syndrome: the past as prologue. Ann Intern
Med 98:401403, 1983.
54.Waitzman MB, Kaplan H, Cornelius L, Evatt B, Hunt
B. Aspirin and prostacyclin treatment of diabetic
dogs. Metabolic, Pediatric, Systemic Ophthalmology
7:153158, 1983.
55.Evatt BL, Ramsey RB, Lawrence DN, Zyla LD, Curran
JW. The acquired immunodeficiency syndrome in patients
with hemophilia. Ann Intern Med 100:499504, 1984.
56.Ramsey RB, Palmer EL, McDougal JS, Kalyanaraman VS,
Jackson DW, Chorba TL, Holman RC, Evatt BL. Antibody to
lymphadenopathyassociated virus in hemophiliacs with and
without AIDS. Lancet ii:397398, 1984.
57.Palmer EL, Ramsey RB, Feornio PF, Harrison AK,
Cabradilla C, Francis DP, Poon MC, Evatt BL. Human
Tcell leukemia virus in lymphocytes of two hemophiliacs
with the acquired immunodeficiency syndrome. Ann Intern
Med 101:293297, 1984.
58.Evatt BL, Chorba TL. Acquired immunodeficiency
syndrome (AIDS) in hemophilia. In: Clinics in
Laboratory Medicine. Triplett DA, ed. W.B. Saunders
Company 4:33344, 1984.
59.Triplett DA, Evatt BL, van den Besselaar AMHP.
Proficiency testing and standardization of prothrombin
time potential use of thromboplastin calibration in the
United States. In: Thromboplastin Calibration and Oral
Anticoagulant Control. van den Besselaar AMHP, Gralnick
HR, Lewis SM. Martinus Nijhoff Publishers pp. 209221,
1984.
60.Evatt
BL. Update on AIDS. In: Hematology Beyond the
Microscope (Proceedings of the 4th Technicon
International Hematology Colloquim). Simson E, ed.
Technicon Instruments Corporation, pp. 18391, 1984.
61.Jason J, Evatt B, Chorba T, Ramsey R. Acquired
immunodeficiency syndrome (AIDS) in hemophiliacs. Scand
J Hematol 33(suppl 40):34956, 1984.
62.Griffin JH, Bezeaud A, Evatt B, Mosher D. Studies
of protein C in thromboembolic disease. La Ricerca Clin
Lab 14:469473, 1984.
63.Evatt BL, Jason JM. Perspective comprehension of
AIDS. Proc 4th Int Symp, pp. 97102, 1984.
64.Evatt BL, Chorba TL, McGrady GA, Jason JM. AIDS in
hemophilia. Proc 4th Int Symp, pp. 114, 1984.
65.Van
Den Beesselaar AM, Evatt BL, Brogan DR, Triplett DA.
Proficiency testing and standardization of prothrombin
time: effect of thromboplastin, instrumentation, and
plasma. Amer Journ Clin Path. 82(6):688-99, 1984.
66.Tsakok FH, Koh S, Chua SE, Ratnam SS, Tyler CW,
Layde P, Evatt BL. Effects of norethisterone on
coagulation and fibrinolysis in Asian women. Singapore
Med Journ. 25(6):442-8, 1984.
67.Evatt BL, Gomperts ED, McDougal JS, Ramsey RB.
Coincidental appearance of LAV/HTLVIII antibodies in
hemophiliacs and the onset of the AIDS epidemic. N Engl
J Med 312:483486, 1985.
68.Lederman MM, Ratnoff OD, Evatt BL, McDougal JS.
Acquisition of antibody to lymphadenopathyassociated
virus in patients with classic hemophilia (factor VIII
deficiency). Ann Intern Med 102:753757, 1985.
69.Chorba TL, Jason JM, Ramsey RB, Lechner K,
PabingerFasching I, Kalyanaraman VS, McDougal JS,
Cabradilla CD, Tregillus LC, Lawrence DN, Evatt BL.
HTLVI antibody status in hemophilia patients treated
with factor concentrates prepared from U.S. plasma
sources and in hemophilia patients with AIDS. Thromb
Haemostasis, 1985.
70.McDougal JS, Martin LS, Cort SP, Mozen M, Heldebrant
CM, Evatt BL. Thermal inactivation of the acquired
immunodeficiency syndrome virus, human T lymphotropic
virusIII/lymphadenopathyassociated virus, with special
reference to antihemophilic factor. J Clin Invest 76,
1985.
71.Jason
J, Hilgartner M, Holman RC, Dixon G, Spira TJ, Aledort
L, Evatt BL. Immune status of blood product
recipients. JAMA 253:11405, 1985.
72.Jason J, McDougal JS, Holman RC, Stein SF, Lawrence
DN, Nicholson JKA, Dixon G, Doxey M, Evatt BL,
Hemophilia/AIDS Collaborative Study Group. Human
Tlymphotropic retrovirus type
III/lymphadenopathyassociated virus antibody.
Association with hemophiliacs' immune status and blood
component usage. JAMA 253:34093415, 1985.
73.Jason JM, McDougal JS, Cabradilla C, Kalyanaraman
VS, Evatt BL. Human Tcell leukemia virus (HTLVI) P24
antibody in New York City blood product recipients. Am
J Hematol 20:129137, 1985.
74.Kalyanaraman VS, Narayanan P, Feorino P, Ramsey RB,
Palmer EL, Chorba T, McDougal S, Getchell JP, Holloway
B, Harrison AK, Cabradilla CD, Telfer M, Evatt BL.
Isolation and characterization of a human T cell
leukemia virus type II from a hemophiliaA patient with
pancytopenia. EMBO Journal 4:14551460, 1985.
75.Johnson RE, Lawrence DN, Evatt BL, Bregman DJ, Zyla
LD, Curran JW, Aledort LM, Eyster ME, Brownstein AP,
Carman CJ. Acquired immunodeficiency syndrome among
patients attending hemophilia treatment centers and
mortality experience of hemophiliacs in the United
States. Am J Epidemiol 121:797810, 1985.
76.Petricciani JC, McDougal JS, Evatt BL. Case for
concluding that heattreated licensed antihaemophilic
factor is free from HTLVIII. Lancet (Letter) II:89089l,
1985.
77.Stein SF, Evatt BL, McDougal JS, Lawrence DN, Holman
RC, Ramsey RB, Spira TJ. A longitudinal study of
patients with hemophilia: immunologic correlates of
infection with HTLVIII/LAV and other viruses. Blood
66:973979, 1985.
78.Lawrence DN, Jason JM, Bouhasin JD, McDougal JS,
Knutsen AP, Evatt BL, Joist JH. HTLVIII/LAV antibody
status of spouses and household contacts assisting in
home infusion of hemophilia patients. Blood 66:703705,
1985.
79.Gjerset GF, McGrady G, Counts RB, Martin PJ, Jason
J, Kennedy S, Evatt B, Hansen JA.
Lymphadenopathyassociated virus antibodies and T cells
in hemophiliacs treated with cryoprecipitate or
concentrate. Blood 66:718720, 1985.
80.McDougal JS, Martin LS, Cort SP, Mozen M, Heldebrant
CM, Evatt BL. Thermal inactivation of the acquired
immunodeficiency syndrome virus, human T lymphotropic
virusIII/lymphadenopathyassociated virus, with special
reference to antihemophilic factor. J Clin Invest
76:875877, 1985.
81.McDougal JS, Jaffe HW, Cabridilla CD, Sarngadharan
MG, Nicholson JKA, Kalyanaraman VS, Schable CA,
Kilbourne B, Evatt BL, Gallo RC, Curran JW. Screening
tests for blood donors presumed to have transmitted the
acquired immunodeficiency syndrome. Blood 65:772775,
1985.
82.Gomperts ED, Feorino P, Evatt BL, Warfield D, Miller
R, McDougal JS. LAV/HTLVIII presence in peripheral
blood lymphocytes of seropositive young hemophiliacs.
Blood 65:15491552, 1985.
83.Lange JV, Mitchel SW, McCormick JB, Walker DH, Evatt
BL, McCormick JB, Walker DH, Evatt BL, Ramsey RB.
Kinetic study of platelets and fibrinogen in Lassa
virusinfected, monkeys and early pathologic events in
Mopeia virusinfected monkeys. Am J Trop Med Hyg
34:9991007, 1985.
84.Chorba TL, Brynes R, Kalyanaraman VS, Telfer M,
Ramsey R, Mawle A, Palmer EL, Chen ATL, Feorino PM,
Evatt BL. Transformed T lymphocytes infected by a novel
isolate of human T cell leukemia virus type II. Blood
66:13361342, 1985.
85.Palmer EL, Harrison AK, Ramsey RB, Feorino PM,
Francis DP, Evatt BL, Kalyanaraman VS, Martin ML.
Detection of two human T cell leukemia/lymphotropic
viruses in cultured lymphocytes of a hemophiliac with
acquired immunodeficiency syndrome. J Infect Dis
151:559563, 1985.
86.Kellar KL, Rolovic Z, Evatt BL, Sewell ET.
Characteristics of rat megakaryocyte colonies and their
progenitors in agar culture. Exp Hematol 13:10181024,
1985.
87.Chorba T, Coccia P, Holman RC, Tattersall P,
Anderson LJ, Sudman J, Young NS, Kurczynski E, Saarinen
UM, Moir R, Lawrence DN, Jason JM, Evatt B. The role of
parvovirus B19 in aplastic crisis and erythema
infectiosum (fifth disease). J Infect Dis 154:383393,
1986.
88.Kellar KL, Rolovic Z, Evatt BL, Sewell ET, Ramsey
RB. Thrombopoietin stimulation of megakaryocytopoiesis
in agar culture. Journ. Progress In Clinica &
Biological Research 215:209213, 1986.
89.Evatt BL, Kellar KL, Ramsey RB. Thrombopoietin:
Past, present and future. In: Megakaryocytes:
Development and Function. Levine RF, Williams NT, Evatt
BL, eds. Alan R. Liss, Inc., pp. 143155, 1986.
90.Fenton JW, Wideman CS, Evatt BL. Thrombin clotting
activity measurement and standardization with
lyophilized plasma. Clin Chem 32:320324, 1986.
91.Evatt
BL, Yobs AR, Essien JDK. Interrelationships of
proficiency testing programs and standardization in
laboratory practice. In: Advances in Coagulation
Testing: Interpretation and Application. Triplett DA,
ed. College of American Pathologists, pp. 273283, 1986.
92.Jason JM, McDougal JS, Dixon G, Lawrence DN, Kennedy
MS, Hilgartner M, Evatt BL. HTLVIII/LAV antibody and
immune status of household contacts and sexual partners
of persons with hemophilia. JAMA 255:212215, 1986.
93.Jason JM, Holman RC, Dixon G, Lawrence DN, Bozeman
LH, Chorba TL, Tregillus, Evatt BL, The Hemophilia/AIDS
Collaborative Study Group. Effects of exposure to
factor concentrates containing donations from identified
AIDS patients. A matched cohort study. JAMA
256:17581762, 1986.
94.Levine RF, Williams NT, Evatt BL, eds.
Megakaryocytes: Development and Function. Alan R.
Liss, Inc., 1986.
95.Ramsey RB, Evatt BL, McDougal JS, Feorino P, Jackson
D. Antibody to human immunodeficiency virus in
factordeficient plasma. Am J Clin Pathol 87:263266,
1987.
96.McGrady GA, Jason JM, Evatt BL. The course of the
epidemic of acquired immunodeficiency syndrome in the
United States hemophilia population. Am J Epidemiol
126:2530, 1987.
97.Chorba TL, Evatt BL. Hemophiliaassociated acquired
immunodeficiency syndrome. In: Principles of
Hematology: Clinical and Laboratory Practice. Bick RL,
ed. ThiemeStratton, Inc. 1987.
98.Chorba TL, Evatt BL. Transfusionassociated AIDS.
In: Blood, Blood Products and AIDS. Madhok R, Forbes
CD, Evatt B, eds. Chapman and Hall Ltd., pp. 1732,
1987.
99.Hall JD, Willis DW, Evatt BL, Jackson DW. Using a
monoclonal antibody to identify patients with type I and
type II von Willebrand's disease. Thrombosis
Haemostasis 57(3):332336, 1987.
100.Hargraves MA, Jason JM, Chorba TL, et al.
Hemophiliac patients' knowledge and educational needs
concerning AIDS. Am J Hematol 126(6):11651172, 1987.
101.Bellinger DA, Nichols TC, Read MS, Reddick RL, and
others. Prevention of occlusive coronary artery
thrombosis by a murine monoclonal antibody to porcine
von Willebrand factor. Proc Natl Acad Sci USA
84(22):81008104, 1987.
102.McGrady
GA, Rettig PJ, Istre GR, Jason JM, and others. An
outbreak of necrotizing enterocolitis. Association with
transfusions of packed red blood cells. Am J Epidemiol
126(6):11651172, 1987.
103.Evatt BL, Stein SF. Platelet structure and
function. In: Platelets. Smith DM, Summers SH, eds.
American Association of Blood Banks, pp. 214, 1988.
104.Chorba TL, Evatt BL. Hemophiliaand
TransfusionAssociated AIDS. In: AIDS Principles,
Practices, and Politics. Corless IB, PittmanLindeman M,
eds. Hemisphere Publishing Corporation, pp. 219234,
1988.
105.Jason JM, StehrGreen J, Holman RC, Evatt BL, the
HemophiliaAIDS Collaborative Study Group. Human
immunodeficiency virus infection in hemophilic
children. Pediatrics 82(4):565570, 1988.
106.Kellar KL, Rolovic Z, Evatt BL, Sewell ET, Ramsey
RB. The effects of thrombopoietic activity of rabbit
plasma fractions on megakaryocytopoiesis in agar
cultures. Exp Hematol 16(4):262267, 1988.
107.StehrGreen JK, Holman RC, Jason JM, Evatt BL.
Hemophiliaassociated AIDS in the United States, 1981 to
September 1987. Am J Public Health 78(4):439442, 1988.
108.StehrGreen JK, Jason JM, Evatt BL. Potential effect
of revising the CDC surveillance case definition for
AIDS. Lancet 1(8584):520521, 1988.
109.StehrGreen JK, Evatt BL, Lawrence DN. Acquired
immune deficiency syndrome associated with hemophilia in
the United States. In: Instructional Course Lectures,
Volume XXXVIII. Barr JS, ed., American Academy of
Orthopaedic Surgeons, Vol. 38, pp. 357366, 1989.
110.Jason J, Gomperts E, Lawrence DN, Holman RC,
Bouhasin JD, Miller R, Evatt BL. HIV and hemophilic
children's growth. J Acquired Immune Deficiency
Syndrome 2(3):277282, 1989.
111.Lawrence DN, Jason JM, Holman RC, Heine P, Evatt BL,
the Hemophilia Study Group. Sex practice correlates of
human immunodeficiency virus transmission and acquired
immunodeficiency syndrome incidence in heterosexual
partners and offspring of U.S. hemophilic men. Am J
Hematology 30(2):6876, 1989.
112.Allon M, Soffer O, Evatt BL, Hixon G, Wideman CS.
Protein S and C antigen levels in proteinuric patients:
dependence on type of glomerular pathology. Am J
Hematol 31(2):96101, 1989.
113.Guarner J, Grossman BJ, Judd RL, Wideman CS, Evatt
BL. Multiple arteriovenous malformations of the small
intestine in a patient with protein S deficiency. Amer
J Clin Pathol 92(3):374378, 1989.
114.Horsburgh CR, Jason JM, ... Evatt BL. Duration of
human immunodeficiency virus infection before detection
of antibody. Lancet 637640, Sept. 16 1989.
115.Lairmore MD, Jason JM, Hartley TM, Khabbaz RF, De B,
Evatt BL. Absence of human Tcell lymphotropic virus
type I coinfection in human immunodeficiency
virusinfected hemophilic men. Blood 74(7):25962599,
1989.
116.Jason JM, Ou CY, Moore JL, Lawrence DN, Schochetman
G, Evatt BL, and the HemophiliaAIDS Collaborative Study
Group. Prevalence of human immunodeficiency virus type
1 DNA in hemophilic men and their sex partners. J
Infect Dis 160(5):789794, 1989.
117StehrGreen JK, Jason JM, Evatt BL and the hemophilia
associated AIDS study group. Geographic variability of
hemophiliaassociated AIDS in the United States: effect
of population characteristics. Am J Hematol
32(3):178-183, 1989.
118.Hooper WC, Pruckler J, Jackson D, Evatt BL.
Transforming growth factor-beta induces hemoglobin
synthesis in a human erythroleukemia cell line. Biochem
Biophys Res Commun 165(1):145-150, 1989.
119.Kellar KL, Bridges NB, Monroe MC, Bell BA, Callaway
CS, Evatt BL. Maintenance of normal platelet mass in
anemic Belgrade rats and their response to iron. Exp
Hematol 18(9):979-984, 1990.
120.Horsburgh CR, Ou CY, Jason J, Holmberg SD, ... Evatt
BL. Concordance of polymerase chain reaction with human
immunodeficiency virus antibody detection. J Infect Dis
162(2):542-545, 1990.
121.Holman RC, Gomperts ED, Jason JM, Abildgaard CF, ...
Evatt BL. Age and human immunodeficiency virus
infection in persons with hemophilia in California. Am
J Public Health 80(8):967-969, 1990.
122.Jason JM, Holman RC, Evatt BL, and the Hemophilia
AIDS Collaborative Study Group. Relationship of
partially purified factor concentrates to immune tests
and AIDS. Am J Hematol 34(4):262-269, 1990.
123.Jason JM, Evatt BL, and the Hemophilia-AIDS
Collaborative Study Group. Pregnancies in human
immunodeficiency virus-infected sex partners of
hemophilic men. Am J Dis Child 144(4):485-490, 1990.
124.Lauer CG, Reid TJ, Wideman CS, Evatt BL, Alving BM.
Free protein S deficiency in a family with venous
thrombosis. J Vasc Surg 12(5):541-544, 1990.
125.Hooper WC, Zaki SR, Pruckler J, Garcia J, Evatt BL.
Phorbol ester induces morphological changes and acidic
fibroblast growth factor RNA expression in the RD/TE 671
cell line. Pathobiology 58(4):198-203, 1990.
126.Zaki SR, Austin GE, Swan DC, Hooper WC, ... Evatt
BL. Studies of myeloperoxidase gene expression at the
cellular level by in situ hybridization. Leukemia
4(12):813-818, 1990.
127.Hooper WC, Zaki SR, Pruckler J, Garcia J, Evatt BL.
horbol ester induces morphological changes and acidic
fibroblast growth factor RNA expression in the RD/TE 671
cell line. Pathobiology. 58(4):198-203, 1990.
128.Black CM, McDougal JS, Evatt BL, Reimer CB. Human
markers for IgG2 and IgG4 appear to be on the same
molecule in the chimpanzee. Immunology 72(1):94-98,
1991.
129.Judd R, Zaki SR, Coffield LM, Evatt BL. Sinonasal
papillomas and human papillomavirus; human
papillomavirus 11 detected in fungiform Schneiderian
papillomas by in situ hybriization the polymerase chain
reaction. Human Path. 22(6):550-6, 1991.
130.Stehr-Green JK, Evatt BL, Lawrence DN. Presenting
transfusion-transmitted infections in persons with
hemophilia. In: Transfusion Transmitted Infections.
Smith DM, Dodd RY, eds. American Society of Clinical
Pathologists Press, pp. 271-285, 1991.
131.Hooper WC, Pruckler J, Jackson D, Evatt BL. The
synergistic effect of hemin and transforming growth
factor-beta on hemoglobin accumulation in HEL
erythroleukmia cells. Leukmia Research. 15(8):753-8,
1991.
132.Hooper WC, Jackson D, Pruckler J, Evatt BL.
Cellular kinetics of transforming growth factor-beta
induced hemoglobin accumulation in the HEL
erythroleukemia cell line. Leukemia Research.
15(8):745-51, 1991.
133.Stahl CP, Zucker-Franklin D, Evatt BL, Winton EF.
Effects of human interleukin-6 on megakaryocyte
development and thrombocytopoiesis in primates. Blood.
78(6):1467-75, 1991.
134.Stahl CP, Winton EF, Monroe MC, Holman RC, Zelasky
M, Liehl E, Myers LA, McClure H, Anderson D, Evatt BL.
Recombinant human granulocyte-macrophage
colony-stimulating factor promotes megakaryocyte
maturation in nonhuman primates. Experimental
Hematology. 19(8):810-6, 1991.
135.Judd R, Zaki SR, Coffield LM, Evatt BL. Human
papillomavirus type 6 detected by the polymerase chain
reaction in invasive sinonasal papillary squamous cell
carcinoma. Archives of Path & Lab Med. 115(11):1150-3,
1991.
136.Ambrosino DM, Black CM, Plikaytis BD, Reimer CB, Lee
MC, Evatt BL, Carlone GM. IgG subclass values in black
and white children. Journ. Ped. 119(6):875-9, 1991.
137.Holman RC, Rhodes PH, Chorba TL, Evatt BL. Survival
of Hemophilic Males with Acquired Immunodeficiency
Syndrome With and Without Risk Factors for AIDS Other
Than Hemophilia. Amer. Journ. Hematology 39:275-282,
1992.
138.Holman RC, Chorba TL, Clarke MJ, Evatt BL.
Epidemiology of AIDS in Females with Hemophilia and
Other Chronic Bleeding Disorders in the United States:
Comparisons with Males with Chronic Bleeding Disorders
and AIDS and with Nonhemophilic Female Blood-Transfusion
Recipients with AIDS. Amer. Journ. Hematology 41:19-23,
1992.
139.Fricke W, Augustyniak, Lawrence D, Brownstein A,
Kramer A, Evatt BL. Human immunodeficiency virus
infection due to clotting factor concentrates: results
of the Seroconversion Surveillance Project. Transfusion.
Vol. 32, No 8--1992
140.Zaki SR, Judd R, Coffield LM, Greer P, Rolston F,
Evatt BL. Human papillomavirus infection and anl
carcinoma. Retrospective analysis by in situ
hybridization and the polymerase chain reaction. Amer
Journ Path. 140(6):1345-55, 1992.
141.Zucker-Franklin D, Hooper WC, Evatt BL. Human
lymphotropic retroviruses associated with mycosis
fungoides: evidence that human T-cell lymphotropic virus
type II (HTLV-II) as well as HTLV-I may play a rol in
the disease. Blood. 80(6):1537-45, 1992.
142.Fukuhara T, Hooper WC, Baylin SB, Benson J, Pruckler
J, Olson AC, Evatt BL, Vogler WR. Use of the polymerase
chain reaction to detect hypermethylation in the
calcitonin gene. A new, sensitive approach to monitor
tumor cells in acute myelogenous leukemia. Leukemia
Research. 16(10):1031-40, 1992.
143.Stahl CP, Winton EF, Monroe MC, Haff E, Holman RC,
Myers L, Liehl E, Evatt BL. Differential effects of
sequential, simultaneous, and single agent interleukin-3
and granulocyte-macrophage colony-stimulating factor on
megakaryocyte maturation and platelet response in
primates. Blood, 80(10):2479-85, 1992
144.Phillips DJ, Greengard JS, Fernandez JA, Ribeiro M,
Evatt BL, Griffin JH, Hooper WC. Protein S, an
Antithrombotic Factor, Is Synthesized and Released by
Neural Tumor Cells. Journ. Neurochmistry. 61(1):
1993.
145.Chorba TL, Holman RC, Evatt BL. Heterosexual and
mother-to-child transmission of AIDS in the hemophilia
community. Pub. Hlth Rep 108(1):99-105, 1993 .
146.Stahl CP, Wideman CA, Spira TJ, Haff EC, Hixon GJ,
Evatt BL. Protein S Deficiency in men with Long-term
Human Immunodeficiency Virus Infection. Blood.
81(7):1801-1807, 1993.
147.Stahl CS, Callaway C, Chu MC, Huang GH, Monath TP,
Trent D, Evatt BL. Replication of Colorado tick fever
virus within human hematopoietic progenitor cells. J
Virol 67(4):2389-95, 1993.
148.Hilgartner MW, Donfield SM, Willoughby A, Contant CF
Jr., Evatt BL, et al. Hemophilia growth and development
study. Design, methods and entry data. Am J Pediatr
Hematol Oncol 15(2):208-18, 1993.
149.Lin
JC, Lin SC, De BK, Weng-Pan C, Evatt BL. Precision of
Genotyping of Epstein-Barr Virus by Polymerase Chain
Reaction Using Three Gene Loci (EBNA-2, EBNA-3C, and
EBER): Predominance of Type A Virus Associated with
Hodgkin's Disease. Blood. 81(12):3372-81, 1993.
150.Evatt B. HIV Infection at home and in the
workplace. [Review], Journal of Clinical Apheresis
8(3):161-7; discussion 181-6, 1993.
151.Phillips DJ, Greengard JS, Fernandez JA, Ribeiro M,
Evatt BL, Griffin JH, Hooper WC. Protein S, an
antithrombotic factor, is synthesized and released by
neural tumor cells. J Neurochem. 61(1):344-7, 1993.
152.Black CM, McDougal JS, Holman RC, Evatt BL, Reimer
CB. Cross-reactivity of 75 monoclonal antibodies to
human immunoglobulin with sera of non-human primates.
Immunology Letters. 37(2-3):207-12, 1993.
153.Griffin JH, Evatt B, Wideman C, Fernandez JA.
Anticoagulant protein C pathway defective in majority of
thrombophilic patients. Blood. 82(7):1989-93, 1993.
154.Sun
Xi, Evatt BL, Griffin JH. Blood coagulation factor Va
abnormality associated with resistance to activated
protein C in venous thrombophilia. Blood.
83(11):3120-3125, 1994.
155.
Greengard J, Sun Xi, Xu Xiao, Fernandez J, Evatt BL,
Griffin J. Activated protein C resistance caused by
ARG506Gln mutation in factor V. Lancet 343:1361-2,
1994.
156.Cadroy
Y, Hanson SR, Kelly AB, Marzec UM, Evatt BL, Kunicki TJ,
Montgomery RR, Harker LA. Relative Antithrombotic
Effects of Monoclonal Antibodies Targeting Different
Platelet Glyprotein-Adhesive Molecule Interations in
Nonhuman Primates. Blood, Vol. 83(11):3218-3224, 1994.
157.Phillips DJ, Evatt BE, Hooper WC. Development of an
Elisa for Quantification of Human Protein S in Cell
Culture Fluids Using Commercial Polyclonal Antisera. J
Immunoassay, 15(4):411-428, 1994.
158.Hooper WC, Phillips DJ, Ribeiro MJA, Benson JM,
George VG, Ades EW, Evatt BL. Tumor necrosis
factor-alpha downregulates protein S secretion in human
microvascular and umbilical vein endothelial cells but
not in the HepG-2 hepatoma cell line. Blood 84:483-9,
1994.
159.Hooper WC, Phillips DJ, Ribeiro M, Benson J, Evatt
BL. IL-6 Upregulates Protein S Expression in the HepG-2
Hepatoma Cells. Thrombosis and Haemostasis, 73
(5):819-24, 1995.
160.Ribeiro MJA, Phillips DJ, Benson J, Evatt BL, Ades
EW, Hooper WC. Hemostatic properties of the SV-40
transfected human microvascular endothelial cell line
(HMEC-1). Thromb Research. 79:153-61, 1995.
161.Hooper WC, Phillips DJ, Evatt BL. Endothelial cell
protein S synthesis is upregulated by the complex of
IL-6 and soluble IL-6 receptor. Throm Haemostasis.
77:1014, 1997
162.Hooper WC, Phillips DJ, Evatt BL. TNF-alpha
suppresses IL-6 upregulation of protein S in HepG-2
hepatoma cells. Throm Research. 81:307, 1996.
163.Jason J, Sleeper A, Donfield SM, Murphy J, Warrier,
Arkin S, Evatt BL, and the Hemophilia Growth and
Development Study. Evidence for a Shift from a Type I
Lymphocyte Pattern with HIV Disease Progression. J
Acquired Immune Deficiency Syndromes and Human
Retrovirology 10:471-476, 1996.
164.Evatt, BL. AIDS and Hemophiia--Current Issues.
Thromb Haemostasis. 74:36-39, 1995.
165.Benson JM, Phillips DJ, Holloway BP, Evatt BL,
Hooper WC. Oligonucleotide ligation assay for detection
of the factor V mutation (Arg506->Gln) causing protein C
resistance. Thrombosis Research. 83:1;87-96, 1996.
166.Phillips DJ, Novinger MS, Evatt BL, Hooper WC. TNF
alpha suppressed IL-1 alpha and IL-6 upregulation of
C4b-binding protein in HepG-2 Hepatoma cells. Throm Res
81(3):307-314, 1996.
167.Hooper WC, Dilley A, Ribeiro MJA, Benson J, Austin
H, Silva V, Rawlins P, Wenger NK, Evatt BL. A Racial
Difference in the Prevalence of the Arg506-->Gln
Mutation. Throm Res 81(5):577-581, 1996.
168.Evatt, BL. The CDC: Emphasis on Control and
Prevention. National Hemophilia Foundation Community
Alert Pamphlet, p 4-5, June 1996.
169.Evatt BL. Blood Safety: Role of Suspected and
Unexpected Infection Agents. [Report] from the Canadian
Hemophilia Society Representatives, for the Dublin,
Ireland June 23-28, 1996 Conference, page 8.
170.Evatt. Disease Progression and Survival Rate Among
the Hemophilia Population. Presented for the Canadian
Hemophilia Society at the XI International Conference on
AIDS, Vancouver 1996. [Report]from the Canadian
Hemophilia Society Representatives, July 7-12, 1996,
pp15-16.
171.Lobato MN, Hannan J, Simonds RJ, Riske B, Evatt BL.
Attitudes, Practices and Infection Risks of Hemophilia
Treatment Center Nurses Who Teach Infection Control for
the Home. Infection Control and Hospital Epidemiology.
17(11):726-731, 1996.
172.Smith PS, Teutsch SM, Shaffer PA, Rolka H, Evatt
BL. Episodic versus prophylactic infusions for
hemophilia A: A cost-effectiveness analysis. J Peds.
129(3):424-431, 1996.
173.
Evatt BL, Chorba TL, McGrady, GA, Jason JM. AIDS in
Hemophilia. Proceedings of the 4th Technicon
International Symposium pp 1-14, 1984.
174.
Hooper, WC, Dilley A, Austin H, Wenger NK, Benson J,
Evatt BL, Silva V, Rawlins P. Absence of Mutations of
APC Clevage Sites Arg306 in Factor V and Arg336, Arg562
in Factor VIII in African-Americans. Thromb Haemost
79:236, 1998.
175.
Evatt BL, Hooper WC. Infectious Complications of Blood
Products. Hemophilia. ed CD Forbes, L Aledort, R
Madlock. 1997, p 249.
176.
Dilley A, Austin H, Hooper WC, Lally C, Riberio MJA,
Wenger NK, Silva V, Rawlins P, Evatt BL. Relations of
Three Genetic Traits to Venous Thrombosis in an
African-American Population. American Journal of
Epidemiology 147(1): 1998.
177.Evatt, BL. Prions and Haemophilia: Assessment of
Risk. Haemophilia 4: 628-633, 1998.
178.
Evatt, BL. Public Health and International Health-Care
Development for Persons with Haemophilia: Operation
Improvement and Operation Access. Haemophilia
4(Suppl.2):54-58, 1998.
179.Evatt, BL. Control of Haemophilia: Haemophilia Care
in Developing Countries. World Health Organization,
WHO/HGN/WFH/WG/98.3. 1997.
180.
JM Soucie, BH Robertson, BP Bell, KA McCaustland BL
Evatt. Hepatitis A virus associated with clotting
factor concentrate in the United States. Transfusion
38:573-579, 1998.
181.WC
Hooper, DJ Phillips, MA Renshaw, BL Evatt, JM Benson.
The Up-regulation of IL-6 and IL-8 in Human Endothelial
Cells by Activated Protein C. J Immunology
161:2567-2573, 1998.
182.
Hooper WC, Evatt BL. The role of activated protein C
resistance in the pathogenesis of venous thrombosis. Am
J Med Sci. 316:120-128, 1998.
183.
Austin H, Hooper WC, Dilley A, et al. The Prevalence of
Two Genetic Traits Related to Venous Thrombosis in
Whites and African-Americans. Thromb Res 86(5):409-15,
1997.
184.
Dilley A, Austin, H, Hooper, WC, et al. The Prevalence
of the Prothrombin 20210 G to A Variant in
African-Americans; Infants, Venus Thrombosis Patients,
myocardial Infarction patients, and Controls. J Lab
Clin Med 132:452-455, 1998.
185.Soucie JM, Jackson, D, Evatt BL. The Occurrence of
Hemophilia in the United States. AM J Hematol.
59:288-298, 1998.
186.Evatt B, Austin H, Barnhart E, Schonberer L, Sharer
L, Jones R, DeArmond S. Surveillance of
Creutzfeldt-Jakob disease among persons with hemophilia.
Transfusion, 38:817-820, 1998.
187.Chroba TL, Holman RC, Strine TW, Clarke MJ, Evatt
BL. Changes in longevity and causes of death among
persons with hemophilia A. American J Hematology
45:112-121, 1994.
188.BL
Evatt, H Austin, G Leon, A Ruiz-Saez, N DeBosch
Predicting the long-term risk of HIV exposure by
cryoprecipitate. Hemophilia 6(Suppl 1):128-132, 2000.
189.BH
Robertson, MJ Alter, BP Bell, BL Evatt, KA McCaustland,
CN Shapiro, SD Sinha, JM Soucie. Hepatitis A Virus
Sequences Detected in Clotting Factor Concentrates
Associated with Disease Transmission. Biologicals
26:95-99, 1998
190.CL
Philipp, A Dilley; P Saidi, BL Evatt, H Austin, J
Zawadsky, D Harwood, D Ellingsen, E Barnhart, DJ
Phillips, WC Hooper. Deletion Polymorphism in the
Angiotensin-converting Enzyme Gene as a Thrombophilic
Risk Factor after Hip Arthroplasty. Thromb Haemostasis
80:869-73, 1999.
191. BL
Evatt, H Austin, G Leon, A Ruiz-Saez, N DeBosch
Hemophilia therapy: assessing the cumulative risk of
HIV exposure by cryoprecipiate. Hemophilia 5,295-300,
1999.
192.CL
Philipp, A Dilley; P Saidi, BL Evatt, H Austin; J
Zawadsky, D Harwood, Ellingsen, E Barnhart, DJ Phillips,
WC Hooper. Deletion Polymorphism in the
Angiotensin-converting Enzyme Gene as a Thrombophilic
Risk Factor after Hip Arthroplasty. Thromb Haemostasis
80:869-73, 1999.
193. LC
Richardson, BL Evatt. Risk of Hepatitis A Virus
Infection in Persons with Hemophilia Receiving
Plasma-Derived Products. Transfusion Med Rev 14:64-73,
2000.
194. BL
Evatt. Creutzfeldt-Jakob Disease and Hemophilia:
Assessment of Risk. World Federation of Hemophilia
Monograph #15. January 1999.
195.
Hooper WC. Lally C. Austin H. Benson J. Dilley A. Wenger
NK. Whitsett C. Rawlins P.Evatt BL. The relationship
between polymorphisms in the endothelial cell nitric
oxide synthase gene and the platelet GPIIIa gene with
myocardial infarction and venous thromboembolism in
African Americans. Chest. 116(4):880886, 1999.
196.
Kisker CT. Mahoney EM. Arkin S. Maeder MA. Donfield SM.
Evatt BL. Changes in hepatitis B serologic titers in
HIV+ and HIV children with haemophilia. Haemophilia.
5(5):3549, 1999.
197.
Benson JM. Ellingsen D. Renshaw MA. Resler AG. Evatt BL.
Hooper WC. Multiplex analysis of mutations in four genes
using fluorescence scanning technology. Thrombosis
Research. 96(1):5764, 1999.
198.
Austin H, Hooper WC, Lally C, Dilley A, Ellingsen D,
Wideman C, Wenger NK, Rawlins P, Silva V, Evatt B.
Venous thrombosis in relation to fibrinogen and factor
VII genes among African-Americans. J Clin Epi
53:997-1001, 2000.
199.Dilley A, Austin H, El-Jamil M, Hooper C, Barhhart
E, Evatt BL, Sullivan PS, Elligsen D, Patterson-Barnett
A, Eller D, Randall H, Philipp C. Genetic factors
associated with thrombosis in pregnancy in a United
States population. Am J Obstet Gynecol 183:1271-1277,
2000.
200.
Soucie JM, Nuss R, Evatt B, Abdelhak A, Cowan L, Hill H,
Kolakoski M, Wilber N, and the Hemophilia Surveillance
System Project Investigators. Mortality among males with
hemophilia: relations with source of medical care. Blood
96:437-442, 2000.
1.
201.Collaborative Group on AIDS Incubation and HIV
Survival including the CASCADE EU Concerted Action. Time
from HIV-1 seroconversion to AIDS and widespread use of
highly active antiretroviral therapy: a collaborative
reanalysis. Lancet 355:1131-1137, 2000.
202.Soucie JM, Erdman DD, Evatt BL, Anderson LJ, Torok
TJ, El-Jamil M, Barnhart E, Tepper M, Burrill, HN,
Pickett AM Mengeling WL. Investigation of porcine
parvovirus among persons with hemophilia receiving
Hyate:C porcine factor VIII concentrate. Transfusion 40:
708-711, 2000.
203.Evatt BL, Robillard L. Establishing haemophilia care
in developing countries: using data to overcome the
barrier of pessimism. Haemophilia 6:131-134, 2000.
204.Hooper WC. Lally C. Austin H. Renshaw M. Dilley A.
Wenger NK. Phillips DJ. Whitsett C. Rawlins P. Evatt
BL. The role of the tPA I/D and PAI1 4G/5G
polymorphisms in AfricanAmerican adults with a diagnosis
of myocardial infarction or venous thromboembolism.
Thromb Res 99(3):223230, 2000.
205.Evatt BL. Survival of haemophilia care in the
developed world. Haemophilia. 6(Suppl 2):1112, 2000.
206.Nelson MD. Wilson DA. Kisker CT. Evatt BL.
Fenstermacher MJ. Lynn HS. Donfield SM. Maeder MA.
Incidence of focal white matter lesions in a population
of hemophiliac children and their normal siblings. Ped
Radiology. 30(10):705709, 2000.
207.
Nuss R, Soucie JM, Evatt B et. al., Changes in the
occurrences of and risk factors for
hemophilia-associated intracranial hemorrhage. Am J.
Hematol 2001;68:37-42.
208.
Dilley A. Hooper C. Stokes M. Austin H. El-Jamil M.
Evatt B. The beta-fibrinogen gene G-453-A polymorphism
is a risk factor for Legg-Perthes disease. [Journal
Article] Paediatric & Perinatal Epidemiology. 15(4):A8,
2001.
209.
Dilley A. Hooper WC. El-Jamil M. Renshaw M. Wenger NK.
Evatt BL. Mutations in the genes regulating methylene
tetrahydrofolate reductase (MTHFR C-->T677) and
cystathione beta-synthase (CBS G-->A919, CBS T-->c833)
are not associated with myocardial infarction in African
Americans. Thromb Res. 103(2):109-15, 2001.
210. J.
Dilley A. Austin H. EL-Jamil M. Wolstein L. Doris J.
Hooper WC. Meehan PL. Evatt B. The role of protein C,
protein S, and resistance to activated protein C in
Legg-Perthes disease. Pediatrics. 107(6):1329-34, 2001.
211.
Hooper WC. El-Jamil M. Dilley A. Philipp C. Ellingsen D.
Phillips D. Evatt BL. The relationship between the
tissue plasminogen activator Alu I/D polymorphism and
venous thromboembolism during pregnancy. Thromb Res.
102(1):33-7, 2001.
212.
Soucie JM. Symons J 4th. Evatt B. Brettler D. Huszti H.
Linden J. The Hemophilia Surveillance System Project
Investigators. Home-based factor infusion therapy and
hospitalization for bleeding complications among males
with haemophilia. Haemophilia. 7(2):198-206, 2001.
213.
Hilgartner MW. Maeder MA. Mahoney EM. Donfield SM. Evatt
BL. Hoots WK. Response to measles, mumps, and rubella
revaccination among HIV-positive and HIV-negative
children and adolescents with hemophilia. Hemophilia
Growth and Development Study. Am J of Hematol.
66(2):92-8, 2001.
214.
Heneine W. Switzer WM. Soucie JM. Evatt BL. Shanmugam V.
Rosales GV. Matthews A. Sandstrom P. Folks TM. Evidence
of porcine endogenous retroviruses in porcine factor
VIII and evaluation of transmission to recipients with
hemophilia. Journal of Infectious Diseases.
183(4):648-52, 2001.
215.
Miller CH. Dilley A. Richardson L. Hooper WC. Evatt BL.
Population differences in von Willebrand factor levels
affect the diagnosis of von Willebrand disease in
African-American women. Am J of Hematol. 67(2):125-9,
2001.
216.
Dilley A. Drews C. Miller C. Lally C. Austin H.
Ramaswamy D. Lurye D. Evatt B. von Willebrand disease
and other inherited bleeding disorders in women with
diagnosed menorrhagia. Obstetrics & Gynecology.
97(4):630-6, 2001 Apr.
217.
Soucie JM. Richardson LC. Evatt BL. Linden JV. Ewenstein
BM. Stein SF. Leissinger C. Manco-Johnson M. Sexauer CL.
Hemophilia Surveillance System Project Investigators.
Risk factors for infection with HBV and HCV in a large
cohort of hemophiliac males. Transfusion.
41(3):338-43, 2001 Mar.
218.
Chorba TL. Holman RC. Clarke MJ. Evatt BL. Effects of
HIV infection on age and cause of death for persons with
hemophilia A in the United States. Am J of Hematol.
66(4):229-40, 2001 Apr.
219. Evatt BL. Farrugia A. Shapiro AD. Wilde JT.
Haemophilia 2002: emerging risks of treatment.
Haemophilia. 8(3):221-229, 2002 May.
220.Dilley A. Hooper C. Stokes M. Austin H. El-Jamil M.
Evatt B. The beta-fibrinogen gene G-453-A
polymorphism is a risk factor for Legg-Perthes disease.
Paediatric and Perinatal Epidemiology. 15(4):A8,
2001.
221.Hooper WC. Dowling NF. Wenger NK. Dilley A.
Ellingsen D. Evatt BL. Relationship of venous
thromboembolism and myocardial infarction with the
renin-angiotensin system in African-Americans. Am J of
Hematol. 70(1):1-8, 2002.
222.Evatt BL. Observations from Global Survey 2001: an
emerging database for progress. Haemophilia.
8(2):153-156, 2002.
223.Dilley A. Drews C. Lally C. Austin H. Barnhart E.
Evatt B. A survey of gynecologists concerning
menorrhagia: Perceptions of bleeding disorders as a
possible cause. Journal of Womens Health & Gender-Based
Medicine. 11(1):39-4, 2002.
224.Dilley A. Benito C. Hooper WC. Austin H. Miller C.
El-Jamil M. Cottrell S. Benson J. Evatt BL. Patterson-Bamett
A. Eller D. Philipp C. Mutations in the
factor
V, prothrombin and MTHFR genes are not risk factors for
recurrent fetal loss. Journal of Maternal-Fetal &
Neonatal Medicine.
11(3):176-82, 2002.
225.Miller CH. Dilley AB. Drews C. Richardson L. Evatt
B. Changes in von Willebrand factor and factor VIII
levels during the menstrual cycle. Thrombosis &
Haemostasis. 87(6):1082-3, 2002.
226.Benson JM. Ellingsen D. El-Jamil M. Jenkins M.
Miller CH. Dilley A. Evatt BL. Hooper WC. Factor V
Leiden and factor V R2 allele: high-throughput
analysis and association with venous thromboembolism.
Thrombosis & Haemostasis. 86(5):1188-92, 2001.
